AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

Hormone therapy shifts body proteins to match gender identity

Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...

Targeting 'molecular bodyguards' weakens prostate cancer cells

Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...

Females found to carry a higher genetic risk of depression

An international team of scientists has discovered about twice as many genetic 'flags'...

Content from other channels on our network

Discovery improves silicon solar efficiency

Partnership to redefine thermal comfort index

Dashboard to support climate-aware business decisions

Australia's homes aren’t ready for the heat — here's how to fix them

Program assists power station workers to find new careers

Coal mine land transfer 'a win‍-‍win outcome' for the Upper Hunter: BHP

Australia and Canada sign critical minerals agreement

UNSW scientists advance solar cell efficiency by splitting light

Aussie underwater robot company secures funding for expansion

Roma Foods celebrates over 70 years of Australian manufacturing

Rock lobster exporter improves supply chain efficiency

Butter maker required sanitary measurement solution

CCEP's reverse vending machine rollout

Bottle-filling physics: keeping it calm to prevent sloshing